Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.CRUESPUniversidade Estadual de Campinaspt_BR
dc.typeArtigo de periódicopt_BR
dc.titlePrognostic Factors for Hepatocellular Carcinoma Recurrence: Experience With 83 Liver Transplantation Patientspt_BR
dc.contributor.authorAtaide, ECpt_BR
dc.contributor.authorBoin, IFSFpt_BR
dc.contributor.authorAlmeida, JRSpt_BR
dc.contributor.authorSeva-Pereira, Tpt_BR
dc.contributor.authorStucchi, RSBpt_BR
dc.contributor.authorCardoso, ARpt_BR
dc.contributor.authorCaruy, CAApt_BR
dc.contributor.authorEscanhoela, CAFpt_BR
unicamp.authorAtaide, E. C. Stucchi, R. S. B. Cardoso, A. R. Caruy, C. A. A. Escanhoela, C. A. F. Univ Estadual Campinas, Fac Med Sci, Campinas, SP, Brazilpt_BR
unicamp.authorBoin, I. F. S. F. Almeida, J. R. S. Seva-Pereira, T. Univ Estadual Campinas, Unit Liver Transplantat, Campinas, SP, Brazilpt_BR
dc.subject.wosMicrovascular Invasionpt_BR
dc.description.abstractIntroduction. Orthotopic liver transplantation (OLT) is a rational therapeutic option for early-stage hepatocellular carcinoma (HCC) providing a potential cure and improving survival. Methods. This retrospective study of a longitudinal cohort used an electronic database collected prospectively from September 1997 to May 2010. The variables were gender, age (years), and alpha-fetoprotein (AFP) level (ng/mL). In explanted livers we observed: microvascular or macrovascular invasion, number of nodules and their largest size, Edmondson-Steiner histological differentiation, incidental tumor transarterial chemoembolization (TACE), Milan criteria, and previous down-staging. Results. Five of 83 (6.0%) subjects including 68 (82%) males with a mean time to diagnosis of 9 months experienced tumor relapses. Mean patient age at HCC recurrence was 55.3 years for male and 44.6 years for female subjects. Vascular invasion was detected in 17/83 (20.5%) subjects, namely 2% of macrovascular invasion, and 52.5% with expanded Milan criteria due to an increased number and size of nodules in the explanted livers. An incidental tumor was observed in 29.5% of cases. Preoperative TACE treatment was performed in 13 (15.6%) patients. None of the patients who had a HCC recurrence had undergone TACE. APP level at the time of recurrence was around 1,900 ng/mL. The predictive factor for mortality was nodule size (P = .04; hazard ratio = 0.0269; confidence interval [CI], 95% 0.0094-0.299). Conclusion. Patients with relapses showed the worst survival and tumor size was a predictive factor for
dc.relation.ispartofTransplantation Proceedingspt_BR
dc.relation.ispartofabbreviationTransplant. Proc.pt_BR
dc.publisher.cityNew Yorkpt_BR
dc.publisherElsevier Science Incpt_BR
dc.identifier.citationTransplantation Proceedings. Elsevier Science Inc, v. 43, n. 4, n. 1362, n. 1364, 2011.pt_BR
dc.sourceWeb of Sciencept_BR
dc.description.provenanceMade available in DSpace on 2014-07-30T18:08:38Z (GMT). No. of bitstreams: 0 Previous issue date: 2011en
dc.description.provenanceMade available in DSpace on 2015-11-26T17:40:55Z (GMT). No. of bitstreams: 2 WOS000291289400107.pdf: 471718 bytes, checksum: c4c3311d8904290d653901cd279f9c71 (MD5) WOS000291289400107.pdf.txt: 13279 bytes, checksum: 7947e45829cac58f7ab6e2f2e246a00d (MD5) Previous issue date: 2011en
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File Description SizeFormat 
WOS000291289400107.pdf460.66 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.